Product Reports Resources Pricing Login Book a demo

BC Platforms

Biotech & Life Sciences · Zurich, Switzerland · Founded 1997

A global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice MoreLess

BC Platforms specializes in genomic data management solutions aimed at advancing precision medicine and research. The company integrates clinical and genetic data to provide actionable insights for healthcare providers, research institutions, and pharmaceutical companies. Operating in the global healthcare and biotechnology markets, BC Platforms employs a subscription-based business model, offering its software as a service (SaaS). Revenue is generated through licensing fees, data analytics services, and partnerships with research organizations. The company serves a diverse clientele, including hospitals, universities, and biotech firms, helping them to leverage big data for improved patient outcomes and innovative research.

Keywords: Genomic data, precision medicine, clinical data, genetic insights, healthcare analytics, biotechnology, SaaS, data integration, research partnerships, patient outcomes.

Company overview

BC Platforms company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
1997
Headquarters
Zurich, Switzerland
Employees
107
Open positions
3
Dealroom signal
60.9
Investment activity
2 companies · latest Dec 2023
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryBioTechnologysub industryHealth Platformbusiness modelSaaSindustryHealthsectorAnalyticssectorData AnalyticssectorBiotechnologysectorGenetics and genomicssectorPrecision MedicinesectorSpinoutsectorBiotech and PharmasectorAI Drug DiscoverysectorTechbio

Valuation & funding

BC Platforms funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCEquity / VC Nov 2022 $20M Jolt Capital
SERIES CEquity / VC Dec 2019 $15M $60M Debiopharm Group · Tesi · IQVIA
SERIES BEquity / VC May 2017 $10M $40M Tesi · Debiopharm Group
OtherOther financing Nov 2016 $0 Boston Millennia Partners
SPINOUTOther financing Jan 1997 $0 MIT Sloan School of Management
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $1.1M 0% 104
2025 $1.1M 0% 131
2024 $1.1M 0% 153
2023 $1.1M +6.5% 100
2022 $986K +21.9% 89
2021 $809K +15.9% 79
2020 $698K 67
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

BC Platforms website traffic

Latest recorded traffic for BC Platforms is 4K monthly website visits, down 50% over the last three months. BC Platforms's team declined 18.3% over the past year.

Latest monthly visits4K 3-month web change-50% 1-year team growth-18.3%
Monthly website visits115 observations · Nov 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

BC Platforms compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

BC Platforms's talent

Book a demo to see the people
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on BC Platforms's cap table

Sourced from Dealroom's funding and investor records.

Series A 2 investors entered at this stage
Debiopharm Group
Tesi
Series B+ 2 investors entered at this stage
IQVIA
Jolt Capital
Other known 3 additional known investors
Boston Millennia Partners
MIT Sloan School of Management
StartAngels

Global footprint

Where BC Platforms has talent and traffic

Workforce by country
14 countries with
team presence
🇸🇪 Sweden22%
🇫🇮 Finland22%
🇫🇷 France17.6%
🇬🇧 United Kingdom13.2%
🇺🇸 United States9.9%
Top 5 of 14 shown

In the news

Latest news about BC Platforms

Recent press, funding announcements, and product moves mentioning BC Platforms — open to read from the original sources.

See all news

Market sentiment

What the market is saying about BC Platforms

An AI-synthesized read of the highest-engagement posts about BC Platforms on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BC Platforms’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.